(212) 362-9635
Visit Us Daily 8.00 AM - 6.00 PM
171 W 79th St #2, New York, NY 10024
The most serious risk involved in TMS therapy is the possibility of experiencing a grand mal seizure, but this is a rare side effect. Only 1 in 10,000 patients will experience a grand mal seizure during transcranial magnetic stimulation therapy. Otherwise, the most common side effect is experiencing headaches after the first two or three
The most serious risk involved in TMS therapy is that the procedure could trigger a grand mal seizure in the patient undergoing the process. However, the likelihood of suffering from this side effect is as little as 1 in 10,000. The risk increases substantially in patients who have a prior seizure disorder, raising the odds
As with all kinds of medical treatments, it is important to note that all patients are unique with individual differences that can alter the parameters of the treatment course. With that in mind, it is common for most patients to average about 30 treatments over the course of a month and a half; usually, the
Transcranial Magnetic Stimulation (TMS) is FDA approved [since 2008] for adults who suffer from major depressive disorder and who have failed to find relief from anti-depressants. It is an office procedure where magnetic pulses target the prefrontal cortex of the brain. Our mission is to save lives. One of the easiest and highly effective forms of treatment for depression is TMS Therapy.
